Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, China.
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, China.
Front Endocrinol (Lausanne). 2024 Mar 22;15:1284799. doi: 10.3389/fendo.2024.1284799. eCollection 2024.
Psychosocial status and patient reported outcomes (PRO) [depression and health-related quality-of-life (HRQoL)] are major health determinants. We investigated the association between depression and clinical outcomes in Chinese patients with type 2 diabetes (T2D), adjusted for PRO.
Using prospective data from Hong Kong Diabetes Register (2013-2019), we estimated the hazard-ratio (HR, 95%CI) of depression (validated Patient Health Questionnaire 9 (PHQ-9) score≥7) with incident cardiovascular disease (CVD), ischemic heart disease (IHD), chronic kidney disease (CKD: eGFR<60 ml/min/1.73m) and all-cause mortality in 4525 Chinese patients with T2D adjusted for patient characteristics, renal function, medications, self-care and HRQoL domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression measured by EQ-5D-3L) in linear-regression models.
In this cohort without prior events [mean ± SD age:55.7 ± 10.6, 43.7% women, median (IQR) disease duration of 7.0 (2.0-13.0) years, HbA1c, 7.2% (6.6%-8.20%), 26.4% insulin-treated], 537(11.9%) patients had depressive symptoms and 1923 (42.5%) patients had some problems with HRQoL at baseline. After 5.6(IQR: 4.4-6.2) years, 141 patients (3.1%) died, 533(11.8%) developed CKD and 164(3.6%) developed CVD. In a fully-adjusted model (model 4) including self-care and HRQoL, the aHR of depression was 1.99 (95% confidence interval CI):1.25-3.18) for CVD, 2.29 (1.25-4.21) for IHD. Depression was associated with all-cause mortality in models 1-3 adjusted for demographics, clinical characteristics and self-care, but was attenuated after adjusting for HRQoL (model 4- 1.54; 95%CI: 0.91-2.60), though HR still indicated same direction with important magnitude. Patients who reported having regular exercise (3-4 times per week) had reduced aHR of CKD [0.61 (0.41-0.89)]. Item 4 of PHQ-9 (feeling tired, little energy) was independently associated with all-cause mortality with aHR of 1.66 (1.30-2.12).
Depression exhibits significant association with CVD, IHD, and all-cause mortality in patients with diabetes, adjusting for their HRQoL and health behaviors. Despite the association between depression and all-cause mortality attenuated after adjusting for HRQoL, the effect size remains substantial. The feeling of tiredness or having little energy, as assessed by item Q4 of the PHQ-9 questionnaire, was found to be significantly associated with an increased risk of all-cause mortality after covariate adjustments. Our findings emphasize the importance of incorporating psychiatric evaluations into holistic diabetes management.
心理社会状况和患者报告的结果(PRO)[抑郁和健康相关生活质量(HRQoL)]是主要的健康决定因素。我们调查了在中国 2 型糖尿病(T2D)患者中抑郁与临床结局之间的关联,同时调整了 PRO。
使用香港糖尿病登记处(2013-2019 年)的前瞻性数据,我们使用线性回归模型,根据患者特征、肾功能、药物治疗、自我护理和 HRQoL 领域(移动性、自我护理、日常活动、疼痛/不适、焦虑/抑郁,由 EQ-5D-3L 测量),在 4525 名 T2D 患者中,评估抑郁(经验证的患者健康问卷 9 (PHQ-9)评分≥7)与心血管疾病(CVD)、缺血性心脏病(IHD)、慢性肾脏病(CKD:eGFR<60 ml/min/1.73m)和全因死亡率的风险比(HR,95%CI)。
在这个没有既往事件的队列中[平均年龄±标准差:55.7±10.6,43.7%为女性,中位(IQR)疾病病程为 7.0(2.0-13.0)年,HbA1c,7.2%(6.6%-8.20%),26.4%接受胰岛素治疗],537(11.9%)名患者有抑郁症状,1923(42.5%)名患者在基线时有一定程度的 HRQoL 问题。在 5.6(IQR:4.4-6.2)年后,有 141 名患者(3.1%)死亡,533 名(11.8%)患者发展为 CKD,164 名(3.6%)患者发展为 CVD。在一个包括自我护理和 HRQoL 的完全调整模型(模型 4)中,抑郁的调整后 HR 为 1.99(95%置信区间 CI:1.25-3.18),与 CVD 相关,2.29(1.25-4.21)与 IHD 相关。在调整了人口统计学、临床特征和自我护理的模型 1-3 中,抑郁与全因死亡率相关,但在调整了 HRQoL 后,这种相关性减弱(模型 4-1.54;95%CI:0.91-2.60),尽管 HR 仍然显示出相同的方向和重要的幅度。报告有规律运动(每周 3-4 次)的患者,CKD 的调整后 HR 降低[0.61(0.41-0.89)]。PHQ-9 的第 4 项(感到疲倦,精力不足)与全因死亡率独立相关,调整后的 HR 为 1.66(1.30-2.12)。
在中国 2 型糖尿病患者中,抑郁与 CVD、IHD 和全因死亡率显著相关,同时调整了患者的 HRQoL 和健康行为。尽管在调整了 HRQoL 后,抑郁与全因死亡率之间的相关性减弱,但效应大小仍然很大。PHQ-9 问卷的第 4 项评估的疲倦或精力不足的感觉,在调整了协变量后,与全因死亡率的风险增加显著相关。我们的研究结果强调了将精神评估纳入整体糖尿病管理的重要性。